Characteristics and Motives of College Students Who Engage in Nonmedical Use of Methylphenidate

REFERENCES

• Poulton A. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder. Expert Rev Neurother. 2006; 6: 551–561
   PubMedGoogle Scholar
• http://www.gpoaccess.gov/cfr/retrieve.html Aggregate production quotas. 21 CFR 1303.11; 1970 available online from
   Google Scholar
• Drug Enforcement Administration. Aggregate Production Quota History, http://www.deadiversion.usdoj.gov/quotas/quota_history.htm 2006 available online from
   Google Scholar
• Daley D. Attention deficit hyperactivity disorder: a review of the essential facts. Child Care Health Dev. 2006; 32: 193–204
   PubMed Web of Science ®Google Scholar
• Kessler R C, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163: 716–723
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. The NSDUH Report: Stimulant Use, 2003. Department of Health and Human Services, Rockville, MD 2005, http://www.oas.samhsa.gov/2k5/stimulants/stimulants.pdf available online from
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. Department of Health and Human Services, Rochester, MD, http://dawninfo.samhsa.gov/files/DAWN-ED-2005-Web.pdf DAWN Series D-29, DHHS Publication No. (SMA) 07-4256; 2007 available online from
   Google Scholar
• Substance Abuse and Mental Health Services Administration. College Enrollment Status and Past Year Illicit Drug Use among Young Adults: 2002, 2003, and 2004. 2005
   Google Scholar
• Teter C J, McCabe S E, Lagrange K, Cranford J A, Boyd C J. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006; 26: 1501–1510, http://www.oas.samhsa.gov/2k5/college/college.cfm Rochester, MD: Department of Health and Human Services, available online from
   PubMed Web of Science ®Google Scholar
• Fortson B L, Scotti J R, Del Ben K S, Chen Y-C. Reliability and validity of an Internet traumatic stress survey with a college student sample. J Trauma Stress 2006; 19: 709–720
   PubMed Web of Science ®Google Scholar
• Denscombe M. Web-based questionnaires and the mode effect: an evaluation based on completion rates and data contents of near-identical questionnaires delivered in different modes. Social Science Computer Review. 2006; 24: 246–254
   Web of Science ®Google Scholar
• Harris Interactive, Inc. Harris Interactive [homepage]. Harris Interactive, Inc., Rochester, NY 2007, http://www.harrisinteractive.com/ Accessed July 28, 2007
   Google Scholar
• http://www.harrisinteractive.com/partner/hpolpanel.asp Harris Interactive. Harris Poll Online Panel [Web page]. Harris Interactive Web site. Accessed July 30, 2007
   Google Scholar
• Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health. 2000; 49: 143–145
   PubMed Web of Science ®Google Scholar
• Volkow N D, Swanson J M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003; 160: 1909–1918
   PubMed Web of Science ®Google Scholar
• Morton W A, Stockton G G. Methylphenidate abuse and psychiatric side effects. Primary Care Companion to the Journal of Clinical Psychiatry. 2000; 2: 159–164
   PubMedGoogle Scholar
• Stoops W W, Glaser P E, Rush C R. Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis. Drug Alcohol Depend. 2003; 71: 179–186
   PubMed Web of Science ®Google Scholar
• Ciccone P E, Starr H L, Coleman J, Mrazik T, DuPont R L, Bensinger P B. OROS(r) MPH: a methylphenidate formulation with a low potential for abuse. Annual Meeting, Pediatric Academic Societies, Toronto, OntarioCanada, May, 5–82007. Ortho-McNeil Janssen Scientific Affairs, LLC
   Google Scholar
• Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ. 2001; 165: 1039–1044
   PubMed Web of Science ®Google Scholar
• Kollins S H, Rush C R, Pazzaglia P J, Ali J A. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol. 1998; 6: 367–374
   PubMed Web of Science ®Google Scholar
• Coleman J J, Bensinger P B, Gold M S, Smith D E, Bianchi R P, DuPont R L. Can drug design inhibit abuse?. J Psychoactive Drugs 2005; 37: 343–362
   PubMed Web of Science ®Google Scholar
• Cone E J. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet. Drug Alcohol Depend 2006; 83(Suppl. 1)S31–S39
   PubMed Web of Science ®Google Scholar
• Mansbach R S, Moore R A. Formulation considerations for the development of medications with abuse potential. Drug Alcohol Depend 2006; 83(Suppl. 1)S15–S22
   PubMedGoogle Scholar
• Food and Drug Administration. editor, Rockville, MD, http://www.fda.gov/bbs/topics/news/2007/new.1568.html FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Events, FDA News, 21 February 2007, Doc. No. P07–26; available online from
   Google Scholar
• 1970, Controlled Substances Act. 21 USC 841
   Google Scholar
• 1970, Controlled Substances Act. 21 USC 844
   Google Scholar
• 1970, Controlled Substances Act. 21 USC 843(a)(3)
   Google Scholar
• Harrison A G, Edwards M J, Parker K C. Identifying students faking ADHD: preliminary findings and strategies for detection. Arch Clin Neuropsychol. 2007; 22: 577–588
   PubMed Web of Science ®Google Scholar